Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
SHEPHERD Therapeutics and Oncoheroes Biosciences to Partner for the Discovery, Development and Commercialization of Oncology Therapeutics For Rare Cancers
Tuesday, February 16, 2021SHEPHERD Therapeutics a company dedicated to catalyzing lifesaving treatments for rare cancer patients and Oncoheroes Biosciences a biotech company focused on advancing new therapies for childhood cancer
Avexegen Therapeutics Receives a $2.94M NIH Grant to Advance Treatment for Inflammatory Bowel Disease
Tuesday, February 16, 2021Avexegen Therapeutics Incannounced that it has received a Phase award of million under the National Institutes of Healths Small Business Innovation Research Program SBIR for the development of an oral Neuregulinbased therapy for inflammatory bowel...
FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy
Monday, February 15, 2021The US Food and Drug Administration approved Cosela trilaciclib as the first therapy in its class to reduce the frequency of chemotherapyinduced bone marrow suppression in adults receiving certain types of chemotherapy for extensivestage
Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies
Friday, February 12, 2021Molecular Templates Inc announced that it has entered into a worldwide strategic research collaboration with Bristol Myers Squibb to discover and develop multiple novel therapies designed for specific oncology targets
MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG
Friday, February 12, 2021MindMed a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent nextgen psychedelic compounds with psychedelic or empathogenic properties
I2O Therapeutics Announces Research Collaboration with Sanofi to Enable Oral Delivery of Nanobody-based Medicines
Thursday, February 11, 2021IO Therapeutics developers of a platform for oral delivery of traditionally injectable biological drugs announced today a research collaboration with Sanofi to investigate the oral delivery of Sanofis Nanobodybased medicines which are currently admin...
Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China
Thursday, February 11, 2021Apollomics Inc an innovative biopharmaceutical company committed to the discovery and development of mono and combination oncology therapies and Iterion Therapeutics Inc a venturebacked
Nuance Pharma Announces Strategic Licensing Deal with Antibe Therapeutics in China
Wednesday, February 10, 2021Antibe Therapeutics Inc announced that it has licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region Nuance is a biopharmaceutical company focused on licensing
Hangzhou Chance Pharmaceuticals Expands Pipeline with In-Licensing of AER901 from Aerami Therapeutics
Wednesday, February 10, 2021Hangzhou Chance Pharmaceuticals Chance a clinicalstage biotechnology company focusing on discovering developing and commercializing transformative inhalation therapies for the worlds most debilitating diseases
Hoth Therapeutics Partners with Camargo Pharmaceutical Services for the HT-001 IND, a Treatment for Cancer Patients
Tuesday, February 09, 2021Hoth Therapeutics Inc a biopharmaceutical company today announced that it has signed an agreement with Camargo Pharmaceutical Services to facilitate the writing and submission of the Investigational New Drug application for HT topical product to the...
